PATH vs TECH
Uipath Inc (PATH) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PATH and TECH stock pages for the full models.
Not investment advice.